Product Images Fluzone High Dose Northern Hemisphere

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 2 images provide visual information about the product associated with Fluzone High Dose Northern Hemisphere NDC 49281-467 by Sanofi Pasteur Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Label - fluzonehd 01

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Label - fluzonehd 01

This is a description of an influenza vaccine called FluzoneĀ® High-Dose, specifically formulated for individuals 65 years and older. It is a preservative-free formula for intramuscular use. The vaccine is manufactured by Sanofi Pasteur Inc.*

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Package - fluzonehd 02

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Package - fluzonehd 02

This text provides detailed information about an influenza vaccine with NDC number 4928146765 for the 2023-2024 season. It emphasizes storage instructions, administration method (intramuscular use), and formulation details including the presence of influenza virus strains. The vaccine is manufactured by Sanofi Pasteur Inc. and does not contain preservatives or natural rubber latex. It is also mentioned that the vaccine includes a nonionic surfactant called "Trtone X100." Users are advised to refer to the full prescribing information for additional details.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.